# AbCellera Presents at UBS Biopharma Conference

> AbCellera CEO shares antibody tech advances at UBS Global Biopharma Conference 2026.
- Title: AbCellera Presents at UBS Biopharma Conference · Seekingalpha
- Summary: AbCellera CEO shares antibody tech advances at UBS Global Biopharma Conference 2026.
- Keywords: abcellera, ubs global biopharma conference, antibody technology, gpcrs, ion channels, t cell engagers, carl l hansen, Seekingalpha
- URL: https://shortify.news/Seekingalpha/abcellera-presents-at-ubs-biopharma-conference
- Source: Seekingalpha — https://seekingalpha.com/article/4969173-abcellera-biologics-inc-abcl-presents-at-ubs-global-biopharma-conference-2026-transcript
- Published: 2026-11-17T18:02:53+00:00
- Read time: 1 min
- Topics: abcellera, ubs global biopharma conference, antibody technology, gpcrs, ion channels, t cell engagers, carl l hansen, money, business
## AbCellera CEO
Carl L. Hansen, CEO, President & Chairperson of AbCellera Biologics Inc. (ABCL) presented at UBS Global Biopharma Conference 2026.
## Antibody Platform Focus
AbCellera's 14-year platform targets GPCRs, ion channels, and T-cell engagers with best-in-world technology.
## Biotech Business Model
Company initially served pharma clients before developing its own therapeutics including covid-19 treatments.
## Key takeaway

AbCellera's CEO highlights antibody platform progress targeting GPCRs and ion channels at UBS conference.

---

Summary: Shortify — https://shortify.news/Seekingalpha/abcellera-presents-at-ubs-biopharma-conference
Reporting: Seekingalpha — https://seekingalpha.com/article/4969173-abcellera-biologics-inc-abcl-presents-at-ubs-global-biopharma-conference-2026-transcript

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.